Cyril Deceneux
0000-0002-8074-045X
Publication & Citation Trends
Publications
29 total
Olaparib, durvalumab, and cyclophosphamide, and a prognostic blood signature in platinum-sensitive ovarian cancer: the randomized phase 2 SOLACE2 trial PDF
Cited by 2
OpenAlex
Carnosine Supplementation Has No Effect on Inflammatory Markers in Adults with Prediabetes and Type 2 Diabetes: A Randomised Controlled Trial PDF
Cited by 4
OpenAlex
Polymeric Nanoparticles as a Self‐Adjuvanting Peptide Vaccine Delivery System: The Role of Shape PDF
Cited by 18
OpenAlex
Combining TNFR2-Expressing Tregs and IL-6 as Superior Diagnostic Biomarkers for High-Grade Serous Ovarian Cancer Masses PDF
Cited by 11
OpenAlex
The Development of Surface-Modified Liposomes as an Intranasal Delivery System for Group A Streptococcus Vaccines PDF
Cited by 7
OpenAlex
Poly(hydrophobic Amino Acids) and Liposomes for Delivery of Vaccine against Group A Streptococcus PDF
Cited by 10
OpenAlex
Ropporin-1 and 1B Are Widely Expressed in Human Melanoma and Evoke Strong Humoral Immune Responses PDF
Cited by 5
OpenAlex
Spliced Peptides and Cytokine-Driven Changes in the Immunopeptidome of Melanoma
Cited by 61
OpenAlex
Research Topics
Monoclonal and Polyclonal Antibodies Research
(17)
Protein Degradation and Inhibitors
(16)
Peptidase Inhibition and Analysis
(14)
Immunotherapy and Immune Responses
(8)
Click Chemistry and Applications
(4)
Affiliations
Centre National de la Recherche Scientifique
Inserm
La Trobe University
Austin Hospital
Centre de Recherche en Cancérologie de Lyon